Comparative Safety of Ustekinumab and Vedolizumab in Older Patients with Inflammatory Bowel Disease: A Bicentric Cohort Study

Introduction: Data about the safety of vedolizumab and ustekinumab are lacking in older patients with inflammatory bowel disease. The objective was to compare the safety of vedolizumab and ustekinumab therapies in older patients (>60 years) with inflammatory bowel disease. Methods: This retrospec...

Descripción completa

Detalles Bibliográficos
Autores principales: Burgevin, Alice, Caron, Bénédicte, Sasson, Alexa, Luc, Amandine, Netter, Patrick, Baumann, Cédric, Ananthakrishnan, Ashwin N., Peyrin-Biroulet, Laurent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738147/
https://www.ncbi.nlm.nih.gov/pubmed/36498541
http://dx.doi.org/10.3390/jcm11236967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738147/
https://www.ncbi.nlm.nih.gov/pubmed/36498541
http://dx.doi.org/10.3390/jcm11236967

Ejemplares similares